WO1999061911A2 - Nanometer particles containing a reactive monolayer - Google Patents

Nanometer particles containing a reactive monolayer Download PDF

Info

Publication number
WO1999061911A2
WO1999061911A2 PCT/US1999/007823 US9907823W WO9961911A2 WO 1999061911 A2 WO1999061911 A2 WO 1999061911A2 US 9907823 W US9907823 W US 9907823W WO 9961911 A2 WO9961911 A2 WO 9961911A2
Authority
WO
WIPO (PCT)
Prior art keywords
group
monolayer
mixtures
core
particle according
Prior art date
Application number
PCT/US1999/007823
Other languages
French (fr)
Other versions
WO1999061911A3 (en
Inventor
Royce W. Murray
Allen C. Templeton
Michael J. Hostetler
Jeremy J. Pietron
Original Assignee
University Of North Carolina At Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of North Carolina At Chapel Hill filed Critical University Of North Carolina At Chapel Hill
Priority to CA002329859A priority Critical patent/CA2329859A1/en
Priority to EP99953384A priority patent/EP1073902A2/en
Priority to AU60169/99A priority patent/AU6016999A/en
Publication of WO1999061911A2 publication Critical patent/WO1999061911A2/en
Publication of WO1999061911A3 publication Critical patent/WO1999061911A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346Nanoparticles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004Preparation of sols
    • B01J13/0043Preparation of sols containing elemental metal
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553Metal or metal coated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587Nanoparticles

Definitions

  • the invention generally relates to nanometer-sized particles which have been chemically modified and methods of making the same.
  • nanotechnology relates to the art and science of building molecular materials so that they are capable of functioning as macro-scale structures and/or exhibiting physical and chemical properties which are intermediate between molecular and bulk materials. Applications involving nanotechnology are potentially far reaching. Areas of possible interest relate to, for example, catalysis, molecular electronics, biotechnology, composite materials, solar energy conversion, and the like. Investigative efforts regarding nanotechnology have focused largely on understanding the physical behavior and structure of nanometer-sized materials. Reiss, H., Proceedings of the Welch Foundation 39 th Conference on Chemical Research: Nanophase Chemistry (1995) 49-66 discusses thermodynamic behavior associated with nanophase technology.
  • Nanometer-sized gold particles can be chemically attached to metal surfaces, such as electrodes.
  • the purpose of such experiments is to allow the researcher to add functionality onto the immobilized particles in order to add value to the metal surface.
  • Metal sols are small particles which are insoluble, and thus suspended, in the liquid in which they are dispersed. Numerous recent studies have investigated methods for adding to the complexity of metal sols. For example, Mirkin, C.A., et al., Nature 382 (1996) 607-609, proposes attaching oligonucleotides to gold sols in order to promote aggregation of said sols upon addition of an appropriate complementary oligonucleotide to the sol solution.
  • U.S. Patent No. 4,859,612 to Cole et al. proposes that antibody coated metal sols can interact with an appropriately coated solid phase particle as a means for an immunoassay procedure.
  • Soc, 117:50 (1995) 12537-12548 proposes nanometer- sized gold cores which are stabilized by chemisorbed layers of octane- or hexadecanethiolate. These monolayer-protected gold clusters were found to be highly stable as determined by differential scanning calorimetry techniques.
  • Hostetler, M.J., et al., Langmuir, 12 (1996) 3604-3612 relates to the evaluation of the physical structure of alkanethiolates of various chain lengths adsorbed onto nanometer-sized gold cores. Alkanethiolates with shorter chain lengths were determined to be relatively disordered while materials with longer chain lengths were found to be in the trans zig-zag conformation.
  • the previous three descriptions of the art represent nanometer-sized gold cores covered with simple, non-derivatized alkanethiols, a circumstance that severely limits their applicability.
  • nanometer-sized materials which exhibit specific chemical and physical properties. More particularly, there is a need for such materials which can be tailored for utilization in a number of defined end use applications. It would be particularly desirable if the nanometer-sized particles exhibited flexible chemical behavior as well as
  • the invention relates to a functionalized nanometer- sized particle comprising a core which comprises at least one metal or metal 120 alloy; and a monolayer chemically bonded to the core.
  • the monolayer is formed during the formation of the core and can be modified at any time following formation of the core.
  • the monolayer contains at least one reactive substituent thereon which is coupled to a functional material such that the monolayer becomes chemically modified.
  • the reactive substituent may be 125 selected from a number of groups such as, for example, SH, OH, NH 2 , NH, C0 2 H, SO 3 OH, P0 2 (OH) 2 , BO(OH) 2 , or mixtures thereof.
  • a number of functional materials may be employed such as catalysts, biomaterials, and materials which are chemically, electrochemically, or photochemically active.
  • the particles may be readily
  • the invention in another aspect, relates to a method of making a functionalized nanometer-sized particle.
  • the method comprises providing a nanometer-sized particle comprising: (1) a core which comprises at least one metal or metal alloy and (2) a monolayer chemically bonded to the core, the
  • the nanometer-sized particle is then coupled with a functional material such that the monolayer becomes chemically modified.
  • this method allows for the particle to be modified based on a small subset of reactive substituents, all of which can be readily synthesized or purchased commercially. Adding greater value to said
  • nanometer-sized particle can then be accomplished using a variety of functional materials.
  • FIG. 1 is a representation of a multi-step synthesis of a tripeptide- functionalized monolayer-protected nanometer-sized gold core.
  • FIG. 2a is a graph illustrating the electrochemical characterization of a 10H-(phenothiazine-10)propionic acid-functionalized monolayer-protected nanometer-sized gold core. Specifically, the figure illustrates the cyclic 150 voltammetry of 0.8 mM 70H-(phenothiazine-10)propionic acid (-) in 2:1 toluene/acetonitrile (v/v) at 10OmV/s; and
  • the invention relates to a functionalized nanometer-sized particle.
  • the functionalized nanometer-sized particle comprises a core
  • the core preferably has a diameter ranging from about 1 nm to about 999 nm, more preferably from about 1 nm to about 100 nm; even more preferably from about 1 nm to about 20 nm; and most preferably from about 1 nm to about 7 nm.
  • a monolayer is chemisorbed or chemically bonded to the core. The monolayer
  • 170 contains at least one reactive substituent as described further herein.
  • the reactive substituent(s) on the monolayer is/are coupled to a functional material so as to chemically modify the monolayer.
  • metals and metal alloys may be used in the core.
  • the metal or metal alloy is selected from the group consisting of
  • a semiconducting material a metal oxide material, a Group VIIIA element, a
  • the metal or metal alloy is selected from the group consisting of a Group VIIIA element, a Group IB element, alloys thereof, and mixtures thereof. Examples of elements which may be used include, but are not limited to, gold,
  • Examples of semiconducting materials include, but are not limited to, cadmium sulfide, indium phosphide, and other Group lll-V materials.
  • Example of oxide materials include, but are not limited to, titanium oxide (titania), aluminum oxide (alumina), tin oxide, and iron oxide.
  • the shape of the core is not restricted to any particular 185 geometry, thus, for example, rods, spheres, cuboctahedra, and truncated octahedra, will all satisfy the conditions stated herein.
  • the term "monolayer” may be defined as a layer preferably having a thickness ranging from about 0.4 nm to about 100 nm, and more preferably 1.0 to 20 nm.
  • the monolayer is typically formed during the formation of the core, and the monolayer can be modified at any point following formation of the core.
  • the monolayer which is adsorbed or chemically bonded to the core may comprise a number of materials. Examples of these materials include, but are not limited to, organic compounds (e.g., alkanethiols, arylthiols, vinylthiols,
  • inorganic compounds e.g., alkyl borates, alkyl phosphonates, alkyl silicates), organometallic compounds (e.g., ferrocenethiol); biochemical compounds (e.g., cysteine, albumin, coenzyme A), and mixtures thereof.
  • the monolayer include, for example, branched molecules
  • the monolayer may comprise an alkanethiol or an alkanethiol derivative.
  • Exemplary alkanethiols include those having between 2 and 23 carbon atoms.
  • the monolayer contains at least one reactive substituent.
  • reactive substituent refers to those substituents which are chemically active so that, upon reaction with a functional material, part of the reactive substituent remains with the
  • reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof are employed. Examples of compounds which may be present
  • R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof;
  • E is selected from the group consisting of S, O, NH, COO,
  • n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof.
  • the chemically modified monolayer may also include partially reactive and nonreactive compounds or materials.
  • nonreactive compounds or materials may be used in any ratio so long as at least one reactive compound or material is present on the monolayer.
  • the monolayer is preferably chemically bonded to the core by various types of bonds.
  • bonds include, but are not limited to, core- element-sulfur bonds, core-element-oxygen-bonds, core-element-boron, core-
  • the monolayer is chemically bonded to the core by various core-element-sulfur bonds.
  • core-element refers to any element of which the core is composed.
  • the monolayer is coupled to a functional material such that the monolayer is chemically modified.
  • the term "coupled” may be interpreted to mean that the monolayer and the functional material are linked via formation of a new chemical bond. Examples, include, but are not limited to amide, thioester, and ester-forming reactions known in the art.
  • Examples of functionalities which may be present on the functional materials include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof.
  • Examples of reactive substituents include, but are not limited to, SH, OH, NH 2 , NH, C0 2 H, S0 3 OH, P0 2 (OH) 2 , BO(OH) 2 , and mixtures thereof. More preferably, OH, NH, C0 2 H, NH 2 , and mixtures thereof
  • the functional material may also comprise at least one compound having the general formula:
  • R n (EH) x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound,
  • E is selected from the group consisting of S, O, NH, COO,
  • n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C0 2 , NH 2 , and mixtures thereof. It should be emphasized that the
  • the functional material may be present in the form of a number of structures which possesses functionality in the manner described herein.
  • the functional material may be a catalyst, a biomaterial, a material which is electrochemically active, or combinations thereof.
  • the functional material may also be one which has a low-lying excited state which is capable of undergoing
  • the functional material may also be selected such that the nanometer-sized particle is soluble in a solvent.
  • soluble may be defined to mean the particles being dispersed or dissolved in the solvent.
  • suitable solvents include aqueous or organic solvents.
  • the invention relates to a method of making a functionalized nanometer-sized particle.
  • the method comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core.
  • the monolayer includes at least one reactive substituent.
  • the nanometer-sized particle is then
  • a number of functional materials may be used in the above method. Examples of these materials include, but are not limited to, spin labels (e.g., 4- amino-TEMPO), metal ligands (e.g., 4-(aminomethyl)-pyridine), amino acids
  • chromophores and fluorophores e.g., 1- aminopyrene and 2-naphthaleneethanol
  • ionophores e.g., 2-(aminomethyl)-15- crown-5
  • molecules susceptible to functional group conversion e.g., benzyl amine
  • electroactive molecules e.g., ferrocene methanol, " OH-(phenothiazine- 10) propionic acid, anthraquinone-2-carboxylic acid
  • sugars e.g., ⁇ -D-glucose
  • nucleotides e.g., uridine
  • the coupling step is preferably carried out in the presence of a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
  • a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof.
  • the facilitating reagent may be selected from a base, a catalyst, and mixtures thereof.
  • Preferred bases include various pyridine
  • components which may be employed during the coupling step include, but are not limited to, BOP (benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1- hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4- dimethylaminopyridine); and mixtures thereof
  • the invention in another aspect, relates to a method of analyzing a nanometer-sized particle.
  • the method comprises subjecting a nanometer-sized particle as defined herein to an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
  • an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined.
  • a number of analytical techniques may be employed in this method. Examples of
  • such techniques include, but are not limited to, NMR spectroscopy, electrochemical techniques, fluorescent emission spectroscopies, and infrared spectroscopies. Examples
  • 345 are those that are unique to each functionalized monolayer-protected nanometer-sized gold core (an infrared spectra of a nanometer-sized gold core which is stabilized by chemisorbed layers of dodecanethiolate was used for background subtraction).
  • BOP benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate
  • HOBt 1- hydroxybenzotriazole
  • NMM 4-methylmorpholine
  • DMAP dimethylaminopyridine
  • 4-amino-TEMPO 4-amino-2, 2,6,6-
  • CD 2 CI 2 ⁇ (ppm) - 0.9 (br, 17 H), 1.3 (br, 150 H), 2.75 (br, 0.2 H), 4.0 (br, 2 H), 4.1 (br, 2 H), 6.8 (br, 5.9 H), 7.1 (br, 5.9 H)
  • IR 2851 (d + ), 2921 (d ), 1817, 1733, 1700, 1633, 1616, 1491 , 1411 , 843, 782, 764, 742 cm "1 .
  • the electrochemistry of this MPC derivative is shown in Figure 3a. The percent conversion to number 495 coupled ratio was determined to be 65/7.4.
  • Cyclic voltammetry (seen in Figure 2) was performed with a BAS 100B electrochemical analyzer sold by Bioanalytical Systems, Inc., located in West Lafayette, Indiana. A platinum 3 mm diameter working electrode was polished with 0.5 ⁇ m diamond (Buehler) paste followed by rinsing with water, ethanol, and
  • Thin-layer coulometry (as seen in Figure 2b) was performed using a BAS 590 100B electrochemical analyzer.
  • a 4.3 mm diameter Pt working electrode was polished with 0.5 ⁇ m of diamond (Buehler) paste followed by rinsing with water, ethanol, and acetone and toluene prior to each experiment.
  • a Pt wire counter electrode and Ag wire quasi-reference electrode (AgQRE) resided in a locally designed thin-layer cell as defined in Reilley, C.N., Pure Appl. Chem. 18 (1968) 595 137.
  • a Mitutoyo digital micrometer (1-2", 0.00005" resolution) sold by Mitutoyo

Abstract

A nanometer-sized particle comprises a core comprising at least one metal or metal alloy; and a monolayer chemically bonded to the core. The monolayer contains at least one reactive substituent which is coupled to a functional material such that the monolayer is chemically modified. A method of making a functionalized nanometer-sized particle comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core wherein the monolayer includes at least one reactive substituent; and coupling the nanometer-sized particle with a functional material such that the monolayer is chemically modified.

Description

NANOMETER SIZED PARTICLES CONTAINING A REACTIVE MONOLAYER ADSORBED THEREON AND METHODS OF MAKING THE SAME
Field of the Invention The invention generally relates to nanometer-sized particles which have been chemically modified and methods of making the same.
Background of the Invention Technology involving the synthesis of nanometer-sized particles ("nanotechnology") has gained widespread attention recently. Broadly speaking, nanotechnology relates to the art and science of building molecular materials so that they are capable of functioning as macro-scale structures and/or exhibiting physical and chemical properties which are intermediate between molecular and bulk materials. Applications involving nanotechnology are potentially far reaching. Areas of possible interest relate to, for example, catalysis, molecular electronics, biotechnology, composite materials, solar energy conversion, and the like. Investigative efforts regarding nanotechnology have focused largely on understanding the physical behavior and structure of nanometer-sized materials. Reiss, H., Proceedings of the Welch Foundation 39th Conference on Chemical Research: Nanophase Chemistry (1995) 49-66 discusses thermodynamic behavior associated with nanophase technology. Berry, R.S., Proceedings of the Welch Foundation 39th Conference on Chemical Research: Nanophase Chemistry, (1995), 71-81 focuses on the surface behavior of nanometer-sized particles. Quate, C.F., Proceedings of the Welch Foundation 40th Conference on Chemical Research: Nanophase Chemistry (1996) 87-95, discusses the use of a scanning probe lithography in fabricating nanostructures. Schόn, G., et al., Colloid Polym. Sci. 273 (1995) 202-218, discusses uses of nanometer-sized particles relevant to the microelectronics industry.
Nanometer-sized gold particles can be chemically attached to metal surfaces, such as electrodes. The purpose of such experiments is to allow the researcher to add functionality onto the immobilized particles in order to add value to the metal surface. For example, Freeman, R.G., et al., Science 267
(1995) 1629-1632, propose linking gold and silver colloidal particles to a silanized surface. Doron, A., et al., Langmuir '\'\ (1995) 1313-1317, proposes linking gold colloid particles to an indium tin oxide surface, followed by further functionalizing the exposed edge of the bound colloid particles with electroactive functional groups. The aforementioned techniques may be limited to surface immobilized particles which makes characterization of the end-functionalized material difficult and uncertain. Furthermore, there is a potential general constraint in that the size of the particle attached to the surface is significantly less able to participate in the functionalization reactions. In essence, the aforementioned work may be useful only as a means to add value to a large
(millimeter or micrometer scale) surface.
Metal sols are small particles which are insoluble, and thus suspended, in the liquid in which they are dispersed. Numerous recent studies have investigated methods for adding to the complexity of metal sols. For example, Mirkin, C.A., et al., Nature 382 (1996) 607-609, proposes attaching oligonucleotides to gold sols in order to promote aggregation of said sols upon addition of an appropriate complementary oligonucleotide to the sol solution. U.S. Patent No. 4,859,612, to Cole et al. proposes that antibody coated metal sols can interact with an appropriately coated solid phase particle as a means for an immunoassay procedure. U.S. Patent Nos. 5,294,369 and 5,384,073 to Shigekawa et al. propose that gold sols can be mixed in an alcohol solution containing alkanethiol derivatives. Upon isolation of the particles, antigens, antibodies, and ligands can be further linked to the gold particle via a reaction in an aqueous buffer. In all of the aforementioned examples, the proposed methodology may be limited to metal sols, reactions in heterogeneous media, and a specific subset of functionalized materials. The constraints of the aforementioned methods potentially make analysis of the monolayer difficult and unreliable.
In addition to the above, recent efforts have focused on producing nanometer-sized particles having other materials chemically or physically attached thereto. For example, Brust, M., et al., J. Chem. Soc, Chem. Commun. (1994) 801-802, proposes nanometer-sized gold cores which are stabilized by chemisorbed layers of dodecanethiolate. The resulting material is soluble in non-polar organic solvents and can be repeatedly isolated and reused. Terrill, R. H., et al., J. Am. Chem. Soc, 117:50 (1995) 12537-12548, proposes nanometer- sized gold cores which are stabilized by chemisorbed layers of octane- or hexadecanethiolate. These monolayer-protected gold clusters were found to be highly stable as determined by differential scanning calorimetry techniques. Hostetler, M.J., et al., Langmuir, 12 (1996) 3604-3612, relates to the evaluation of the physical structure of alkanethiolates of various chain lengths adsorbed onto nanometer-sized gold cores. Alkanethiolates with shorter chain lengths were determined to be relatively disordered while materials with longer chain lengths were found to be in the trans zig-zag conformation. The previous three descriptions of the art represent nanometer-sized gold cores covered with simple, non-derivatized alkanethiols, a circumstance that severely limits their applicability.
Hostetler, M.J., et. al., J. Am. Chem. Soc, 118 (1996) 4212-4213 proposes nanometer-sized gold cores stabilized by mixed monolayers of unsubstituted and (^-substituted (cyano, bromo, vinyl, ferrocenyl) alkanethiolates. A potential limitation of this and other methods are that they typically rely on either commercially available or easily-prepared ύΛ-substituted alkanethiols. Another deficiency in these methods is that formation of the ty-substituent often does not occur on the protected gold cores, causing the need for extensive purification steps that can only produce a narrow range of compounds.
100 Notwithstanding the above, there is a need in the art for nanometer-sized materials which exhibit specific chemical and physical properties. More particularly, there is a need for such materials which can be tailored for utilization in a number of defined end use applications. It would be particularly desirable if the nanometer-sized particles exhibited flexible chemical behavior as well as
105 multiplicity with respect to reactivity. It would also be particularly worthwhile if the reverse engineering needed to design the synthesis of an envisioned multi- functionalized nanometer-sized particle would be straightforward and understandable. It would be notably beneficial if the reactions forming the particles were homogeneous, flexible, easy to learn, and reliable. This would be
110 especially advantageous in analytical applications involving the solubilization of the nanometer-sized particles in aqueous or organic solvents.
Summary of the Invention It is therefore an object of the present invention to provide nanometer- 115 sized particles which may be chemically tailored to be desirable in a variety of applications.
These and other objects and features are provided by the present invention. In one aspect, the invention relates to a functionalized nanometer- sized particle comprising a core which comprises at least one metal or metal 120 alloy; and a monolayer chemically bonded to the core. The monolayer is formed during the formation of the core and can be modified at any time following formation of the core. Advantageously, the monolayer contains at least one reactive substituent thereon which is coupled to a functional material such that the monolayer becomes chemically modified. The reactive substituent may be 125 selected from a number of groups such as, for example, SH, OH, NH2, NH, C02H, SO3OH, P02(OH)2, BO(OH)2, or mixtures thereof. By virtue of the nanometer-sized particle structure, a number of functional materials may be employed such as catalysts, biomaterials, and materials which are chemically, electrochemically, or photochemically active. Thus, the particles may be readily
130 used in a number of applications.
In another aspect, the invention relates to a method of making a functionalized nanometer-sized particle. The method comprises providing a nanometer-sized particle comprising: (1) a core which comprises at least one metal or metal alloy and (2) a monolayer chemically bonded to the core, the
135 monolayer including at least one reactive substituent. The nanometer-sized particle is then coupled with a functional material such that the monolayer becomes chemically modified. Importantly, this method allows for the particle to be modified based on a small subset of reactive substituents, all of which can be readily synthesized or purchased commercially. Adding greater value to said
140 nanometer-sized particle can then be accomplished using a variety of functional materials.
Brief Description of the Drawings 145 FIG. 1 is a representation of a multi-step synthesis of a tripeptide- functionalized monolayer-protected nanometer-sized gold core.
FIG. 2a is a graph illustrating the electrochemical characterization of a 10H-(phenothiazine-10)propionic acid-functionalized monolayer-protected nanometer-sized gold core. Specifically, the figure illustrates the cyclic 150 voltammetry of 0.8 mM 70H-(phenothiazine-10)propionic acid (-) in 2:1 toluene/acetonitrile (v/v) at 10OmV/s; and
FIG. 2b is a graph illustrating the thin layer coulometry charge Q vs. cell length (L) (r^O.98; slope=11.47 X 103 C/cm). 155 Detailed Description of the Preferred Embodiments
The present invention now will be described more fully hereinafter with reference to the accompanying specification, examples, and drawings, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as
160 limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
In one aspect, the invention relates to a functionalized nanometer-sized particle. The functionalized nanometer-sized particle comprises a core
165 comprising at least one metal or metal alloy. For the purposes of the invention, the core preferably has a diameter ranging from about 1 nm to about 999 nm, more preferably from about 1 nm to about 100 nm; even more preferably from about 1 nm to about 20 nm; and most preferably from about 1 nm to about 7 nm. A monolayer is chemisorbed or chemically bonded to the core. The monolayer
170 contains at least one reactive substituent as described further herein.
Advantageously, the reactive substituent(s) on the monolayer is/are coupled to a functional material so as to chemically modify the monolayer.
A number of metals and metal alloys may be used in the core. Preferably, the metal or metal alloy is selected from the group consisting of
175 a semiconducting material, a metal oxide material, a Group VIIIA element, a
Group IB element, a Group IIB element, alloys thereof, and mixtures thereof. More preferably, the metal or metal alloy is selected from the group consisting of a Group VIIIA element, a Group IB element, alloys thereof, and mixtures thereof. Examples of elements which may be used include, but are not limited to, gold,
180 silver, copper, palladium, platinum, nickel, and alloys thereof. Examples of semiconducting materials include, but are not limited to, cadmium sulfide, indium phosphide, and other Group lll-V materials. Example of oxide materials include, but are not limited to, titanium oxide (titania), aluminum oxide (alumina), tin oxide, and iron oxide. The shape of the core is not restricted to any particular 185 geometry, thus, for example, rods, spheres, cuboctahedra, and truncated octahedra, will all satisfy the conditions stated herein.
For the purposes of the invention, the term "monolayer" may be defined as a layer preferably having a thickness ranging from about 0.4 nm to about 100 nm, and more preferably 1.0 to 20 nm. Although not wishing to be bound by
190 any one embodiment, the monolayer is typically formed during the formation of the core, and the monolayer can be modified at any point following formation of the core. The monolayer which is adsorbed or chemically bonded to the core may comprise a number of materials. Examples of these materials include, but are not limited to, organic compounds (e.g., alkanethiols, arylthiols, vinylthiols,
195 and their derivatives); inorganic compounds (e.g., alkyl borates, alkyl phosphonates, alkyl silicates), organometallic compounds (e.g., ferrocenethiol); biochemical compounds (e.g., cysteine, albumin, coenzyme A), and mixtures thereof.
In referring to the molecular structure of the monolayer, substituents which
200 may be present on the monolayer include, for example, branched molecules
(e.g., branched alkyl chains, multiply substituted aryl groups, multiply substituted cyclic aliphatic compounds), hyperbranched molecules (e.g., dendritic molecules); and mixtures thereof. As an example of a non-branched substituent, the monolayer may comprise an alkanethiol or an alkanethiol derivative.
205 Exemplary alkanethiols include those having between 2 and 23 carbon atoms.
As alluded to herein, the monolayer contains at least one reactive substituent. For the purposes of the invention, the term "reactive substituent" refers to those substituents which are chemically active so that, upon reaction with a functional material, part of the reactive substituent remains with the
210 product, serving as a linking or coupling group between the original part of the molecule and the new portion of the molecule. Examples of reactive substituents include, but are not limited to, SH, OH, NH2, NH, C02H, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof. More preferably, OH, NH, C02H, NH2, and mixtures thereof are employed. Examples of compounds which may be present
215 on the reactive substituent are described by the general formula:
Rπ(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH, COO,
220 S03OH, P02(OH)2, BO(OH)2, C02, NH2, and mixtures thereof; n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C02, NH2, and mixtures thereof. The chemically modified monolayer may also include partially reactive and nonreactive compounds or materials.
225 Compounds or materials being "partially reactive" refer to those containing groups which do not participate in coupling but instead are capable of undergoing substitution reactions, elimination reactions, oxidative and reductive reactions, and the like. "Nonreactive" compounds or materials refer to those which do not undergo the above reactions. Reactive, partially reactive, and
230 nonreactive compounds or materials may be used in any ratio so long as at least one reactive compound or material is present on the monolayer.
The monolayer is preferably chemically bonded to the core by various types of bonds. Examples of these bonds include, but are not limited to, core- element-sulfur bonds, core-element-oxygen-bonds, core-element-boron, core-
235 element-phosphorus, and core-element-nitrogen-bonds. Combinations of these types of bonds may also be used. In the most preferred embodiment the monolayer is chemically bonded to the core by various core-element-sulfur bonds. In the aforementioned embodiments, core-element refers to any element of which the core is composed.
240 In accordance with the invention, the monolayer is coupled to a functional material such that the monolayer is chemically modified. The term "coupled" may be interpreted to mean that the monolayer and the functional material are linked via formation of a new chemical bond. Examples, include, but are not limited to amide, thioester, and ester-forming reactions known in the art.
245 Examples of functionalities which may be present on the functional materials include, but are not limited to, SH, OH, NH2, NH, C02H, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof. Examples of reactive substituents include, but are not limited to, SH, OH, NH2, NH, C02H, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof. More preferably, OH, NH, C02H, NH2, and mixtures thereof
250 are employed. The functional material may also comprise at least one compound having the general formula:
Rn(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound,
255 and mixtures thereof; E is selected from the group consisting of S, O, NH, COO,
S03OH, P02(OH)2, BO(OH)2, C02, NH2, and mixtures thereof; n is an integer ranging from 1 to 5 (more preferably from 1 to 2); and x is an integer ranging from 1 to 10 (more preferably from 1 to 3). More preferably, E is selected from O, NH, C02, NH2, and mixtures thereof. It should be emphasized that the
260 functional material may be present in the form of a number of structures which possesses functionality in the manner described herein. For example, the functional material may be a catalyst, a biomaterial, a material which is electrochemically active, or combinations thereof. The functional material may also be one which has a low-lying excited state which is capable of undergoing
265 fluorescence or electron-transfer when excited. The functional material may also be selected such that the nanometer-sized particle is soluble in a solvent. The term "soluble" may be defined to mean the particles being dispersed or dissolved in the solvent. Examples of suitable solvents include aqueous or organic solvents.
270 In another aspect, the invention relates to a method of making a functionalized nanometer-sized particle. The method comprises providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto the core. The monolayer includes at least one reactive substituent. The nanometer-sized particle is then
275 coupled with a functional material such that the monolayer is chemically modified.
A number of functional materials may be used in the above method. Examples of these materials include, but are not limited to, spin labels (e.g., 4- amino-TEMPO), metal ligands (e.g., 4-(aminomethyl)-pyridine), amino acids
280 (e.g., glutamic acid d/-£-butyl ester), chromophores and fluorophores (e.g., 1- aminopyrene and 2-naphthaleneethanol), ionophores (e.g., 2-(aminomethyl)-15- crown-5), molecules susceptible to functional group conversion (e.g., benzyl amine), electroactive molecules (e.g., ferrocene methanol, " OH-(phenothiazine- 10) propionic acid, anthraquinone-2-carboxylic acid), sugars (e.g., α-D-glucose),
285 nucleotides (e.g., uridine), and mixtures thereof.
The coupling step is preferably carried out in the presence of a reagent which may be, for example, a phophonium reagent, a facilitating reagent, as well as mixtures thereof. Preferably, the facilitating reagent may be selected from a base, a catalyst, and mixtures thereof. Preferred bases include various pyridine
290 derivatives. Other examples of components which may be employed during the coupling step include, but are not limited to, BOP (benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1- hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4- dimethylaminopyridine); and mixtures thereof
295 In another aspect, the invention relates to a method of analyzing a nanometer-sized particle. The method comprises subjecting a nanometer-sized particle as defined herein to an analytical technique such that the composition of the functional materials of the monolayer on the particle are determined. A number of analytical techniques may be employed in this method. Examples of
300 such techniques include, but are not limited to, NMR spectroscopy, electrochemical techniques, fluorescent emission spectroscopies, and infrared spectroscopies. Examples
305 The examples which follow are set forth to illustrate the invention, and are not meant as a limitation thereon. Although the following examples explicitly employ only monolayer-protected nanometer-sized gold cores, other monolayer- protected nanometer-sized cores (comprising at least one metal or metal alloy which is selected from the group consisting of a semiconducting material, an
310 oxide material, a Group VIIIA element, a Group IB element, a Group IIB element, alloys thereof, and mixtures thereof) have reactivity and stability that allow their use with the reaction conditions set forth below; thus, one skilled in the art could reasonably expect that the examples set forth below would be applicable to all embodiments set forth in the claims of this patent.
315 In the examples, 70 -/-(phenothiazine-10)propionic acid was synthesized according procedures set forth in Peek, B.M. et al., Int. J. Peptide Protein Res. 38 (1991) 114. 11-mercapto-undecanoic acid and 11-mercapto-undecanol were either synthesized according to a procedure described in Bain, CD. et al., J. Am. Chem. Soc 111 (1989) 321; or purchased from the Aldrich Chemical Company
320 of Milwaukee, Wisconsin (95% and 97% purity, respectively). Tetrahydrofuran
(less than 16 ppm water content) was used for all coupling reactions. The synthesis of nanometer-sized gold cores which are stabilized by chemisorbed layers of dodecanethiolate was accomplished in accordance with a procedure described Hostetler, M.J., et al., Langmuir ' 4 (1998) 17-30 and addition of ω-Z-
325 alkanethiol (with Z being COOH or OH) onto the nanometer-sized gold cores was accomplished as described in Hostetler, et al., J. Am. Chem. Soc. 118 (1996) 4212-4213. All other reagents were used as received. Nomenclature for the nanometer-sized gold cores protected by a complex monolayer may be defined as CX:CYZ (a:b) wherein X specifies the length of the alkanethiol chain,
330 Y specifies the chain length of the place exchanged ω-Z-alkanethiol (with Z being
COOH or OH) and (a:b) specifies the mole ratio of X and Y chains in the monolayer on the nanometer-sized gold core as determined from the methyl/CH2R 1H NMR spectral ratio in solutions of nanometer-sized gold cores protected by complex monolayers that have been treated with l2 in order to
335 remove the monolayer from the nanometer-sized gold core as taught in
Templeton, A.C., et al., J. Am. Chem. Soc, 120 (1998) 1906-1911. Percent conversion data was determined using the aforementioned methodology.
With respect to the spectroscopy data, 1H NMR spectra (in C6D6, CD2CI2, or CDCI3) were obtained using a Bruker AMX 200 MHz spectrometer sold by
340 Bruker Instruments, Inc. of Billerica, Massachusetts. A line broadening factor of
1Hz was used to improve the S/N of the NMR resonances belonging to the monolayer on the nanometer-sized gold core. Infrared absorbence spectra of clusters as thin films were acquired using a Biorad 6000 FTIR spectrometer sold by Bio-Rad Laboratories, Inc. of Cambridge, Massachusetts. Reported IR bands
345 are those that are unique to each functionalized monolayer-protected nanometer-sized gold core (an infrared spectra of a nanometer-sized gold core which is stabilized by chemisorbed layers of dodecanethiolate was used for background subtraction).
The examples set forth below employ the following abbreviations for the
350 sake of brevity: THF (tetrahydrofuran); DMF (dimethylformamide); MPC
(monolayer-protected nanometer-sized gold core); BOP (benzotriazol-1- yloxytris(dimethylamino)phosphonium hexafluorophosphate); HOBt (1- hydroxybenzotriazole); NMM (4-methylmorpholine); DMAP (4- dimethylaminopyridine); 4-amino-TEMPO (4-amino-2, 2,6,6-
355 tetramethylpiperidinyloxy, free radical); IR (infrared); NMR (nuclear magnetic resonance); EPR (electron paramagnetic resonance); ml (milliliter); mg (milligram); ppm (parts per million); cm"1 (wavenumbers); d+ (symmetric methylene stretching vibration); d" (antisymmetric methylene stretching vibration); br (broad. All reactions were performed within the temperature range 15 to 35 °
360 C, although one skilled in the art would reasonably assume that the reactions would also be functional in the temperature range -80 to 100 °C. Examples 1-6 Coupling of Amines to C12:C11COOH (a:b)
365 Various coupling reactions were performed according to a procedure set forth in McCafferty et al., Tetrahedron 51 (1995) 1993. In these examples, ca. 100 mg of acid MPC (C12:C11COOH MPC (4:1)) was treated with five equivalents (relative to moles of MPC acid groups) of BOP (60 mg), HOBt (18 mg), NMM (14 uL), and DMAP (16 mg) in low water THF (concentration of 2 mg
370 cluster/mL). Following a brief activation period (10 minutes), five equivalents of a specified amine was added to the reaction mixture and the solution was stirred at room temperature for 15 hours. The solvent was then removed under vacuum and the reacted MPC was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting
375 with 50 mL acetonitrile (3X).
Example 1 4-amino-TEMPO (spin label)
The above procedure was carried out using 4-amino-TEMPO as the 380 amine. The following data were obtained: IR: 2851 (d+), 2922 (d ), 1641 , 1537 cm"1. The EPR spectrum is shown in Figure 2. The percent conversion to number coupled ratio was determined to be 95/13.
Example 2 385 4-(aminomethyl)-pyridine (metal iigand)
The above procedure was carried out using 4-(aminomethyl)-pyridine as the amine. The following data were obtained; NMR (in CD2CI2): δ(ppm) = 0.89 (br, 15.6 H), 1.28 (br, H), 1.74 (br, H), 2.21 (br, 3.1 H), 4.32 (br, 1.9 H), 7.12 (br, 2.3 H), 8.43 (br, 2 H). IR: 2850 (d+), 2920 (d ), 1653, 1602, 1539 cm"1. The 390 percent conversion to number coupled ratio was determined to be 95/9.5. Example 3 glutamic acid di-f-butyl ester (amino acid)
The above procedure was carried out using glutamic acid di-f-butyl ester 395 as the amine. The following data were obtained: NMR (in C6D6): δ (ppm) = 1.02
(br, 27 H), 1.4 (br, 218 H), 2.3 (br, 28 H), 4.8 (br, 2 H). IR: 2850 (d+), 2920 (d"), 1734, 1680, 1650, 1536, 1392, 1367, 1155 cm"1. The percent conversion to number coupled ratio was determined to be 90/4.
400 Example 4
1-aminopyrene (chromophore; fluorophore)
The above procedure was carried out using 1-aminopyrene as the amine. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.85 (br, 3 H), 1.3 (br, 15 H), 1.85 (br, 1.9 H), 3.35 (br, 0.33 H), 3.55 (br, 0.32 H), 7.15 (br, 0.02 H), 405 7.45 (br, 0.04 H), 7.7 (br, 0.06 H), 8.0 (br, 0.18 H). IR: 2851 (d+), 2921 (d"), 1735,
1700, 1655, 1601, 1558, 1517 cm"1. The percent conversion to number coupled ratio was determined to be 95/7.
Example 5 410 2-(aminomethyl)-15-crown-5 (ionophore)
The above procedure was carried out using 2-(aminomethyl)-15-crown-5 as the amine. The following data were obtained: NMR (in C6D6): δ (ppm) = 0.75 (br, 0.8 H), 1.0 (br, 3 H), 1.45 (br, 18 H), 2.25 (br, 2 H), 3.6 (br, 3.8 H). IR: 2949 (d+), 2922 (d"), 1734, 1650, 1543, 1122 cm"1. The percent conversion to number 415 coupled ratio was determined to be 80/8.
Example 6 benzyl amine (group conversion)
420 The above procedure was carried out using benzyl amine as the amine.
The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.90 (br, 31 H), 1.3 (br, 141 H), 2.2 (br, 4 H), 4.4 (br, 3 H), 7.3 (br, 5 H). IR: 2850 (d+), 2920 (d ), 1734, 1646, 1547 cm"1). The percent conversion to number coupled ratio was determined to be 95/7.
425
Examples 7-10 Coupling of alcohols to C12:C11COOH (a:b)
In reactions set forth in these examples, ca. 100 mg of the acid MPC (C12: C11COOH (4:1)) was treated with five equivalents (relative to the moles of
430 MPC acid groups) of BOP (60 mg), HOBt (18 mg), NMM (14 μand DMAP (16 mg) in low water THF (cone, of 2 mg cluster/mL). Following a brief activation period (10 minutes), five equivalents of an alcohol described in these examples was added to the reaction mixture and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the
435 reacted MPC was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting with 50 mL of acetonitrile (3X).
Example 7 440 2-naphthalene-ethanol (chromophore)
The above procedure was carried out using 2-naphthalene-ethanol as the alcohol. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.92 (br, 10 H), 1.3 (br, 69 H), 2.25 (br, 2 H), 3.4 (br, 1.1 H), 3.6 (br, 2 H), 5.9 (br, 0.10 H), 6.5 (br, 0.11 H), 7.15 (br, 0.05 H), 7.4 (br, 0.17 H), 7.8 (br, 0.18 H) IR: 2851 (d+), 445 2922 (d ), 1739, 1653, 1118, 1070 cm"1. The percent conversion to number coupled ratio was determined to be 85/11.5.
Example 8 Ferrocene-methanol (electroactive)
450 The above procedure was carried out using ferrocene-methanol as the alcohol. The following data were obtained: NMR (in C6D6): δ (ppm) = 1.0 (br, 27 H), 1.5 (br, 226 H), 3.9 (br, 5 H), 4.2 (br, 1.3 H), 4.8 (br, 0.9 H) IR: 2851 (d+), 2922 (d ), 1727, 1680, 1594, 1268, 1244IR: 2851 (d+), 2922 (d ), 1737, 1710, 1653, 1616 cm 1. The percent conversion to number coupled ratio was 455 determined to be 50/5.
Example 9 α-D-glucose (sugar)
The same procedure was employed except that α D-glucose was used 460 and a solvent 5:1 THF/DMF was employed to aid glucose solubility. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.9 (br, 3 H), 1.3 (br, 17 H), 2.9 (br, 0.34 H) IR: 2850 (d+), 2920 (d ), 1815, 1733, 1647, 1612, 840,
781 , 769, 740 cm"1. The percent conversion to number coupled ratio was determined to be 35/5.
465
Example 10
Uridine (nucleotide)
The same procedure was employed except uridine was used and a solvent 5:1 THF/DMF was employed to aid uridine solubility. The following data
470 were obtained: NMR (in CD2CI2): δ (ppm) = 0.9 (br, 3 H), 1.3 (br, 17 H), 2.9 (br,
0.85 H) IR: 2851 (d+), 2921 (d"), 1817, 1733, 1700, 1633, 1616, 1491, 1411 , 843,
782, 764, 742 cm"1. The percent conversion to number coupled ratio was determined to be 60/8.
475 Examples 11-12
Coupling of carboxylic acids to C12:C110H (a:b)
In these examples, five equivalents (relative to moles of MPC alcohol) of a carboxylic acid was treated with five equivalents of BOP (60 mg), HOBt (18 mg), NMM (14μL), and DMAP (16 mg) in low water THF (cone, of 2 mg cluster/mL). 480 Following a brief activation period (10 minutes), ca. 100 mg of the alcohol
(C12:C110H (4:1)) was added and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the reacted MPC was collected on a frit where unreacted materials were removed by washing with 500 mL of acetonitrile followed by sonication/decanting with 50 mL acetonitrile 485 (3X).
Example 11 10H-(phenothiazine-10)propionic acid (electroactive)
The above procedure was carried out using 0H-(phenothiazine- 490 10)propionic acid as the acid. The following data were obtained: NMR (in
CD2CI2): δ (ppm) - 0.9 (br, 17 H), 1.3 (br, 150 H), 2.75 (br, 0.2 H), 4.0 (br, 2 H), 4.1 (br, 2 H), 6.8 (br, 5.9 H), 7.1 (br, 5.9 H) IR: 2851 (d+), 2921 (d ), 1817, 1733, 1700, 1633, 1616, 1491 , 1411 , 843, 782, 764, 742 cm"1. The electrochemistry of this MPC derivative is shown in Figure 3a. The percent conversion to number 495 coupled ratio was determined to be 65/7.4.
Example 12 Anthraquinone-2-carboxylic acid (electroactive; chromophore)
500 The above procedure was carried out using anthraquinone-2-carboxylic acid as the acid. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.88 (br, 17 H), 1.3 (br, 119 H), 1.8 (br, 14 H), 3.55 (br, 1.8 H), 4.3 (br, 2 H), 7.8 (br, 1.8), 8.3 br, 3.4 H), 8.8 (br, 0.93 H) IR: 2851 (d+), 2922 (d ), 1727, 1680, 1594, 1268, 1244 cm"1. The percent conversion to number coupled ratio was
505 determined to be 75/7.5.
Example 13 Coupling of BOC-phenylalanine
Five molar equivalents of BOC-phenylalanine (168 mg) were activated (10 510 minutes) by treatment with five equivalents of BOP (280 mg), HOBt (87 mg),
NMM (128 μL), and DMAP (77 mg) in THF (cone, of 2 mg cluster/mL). 200 mg of 3:1 C12:C1110H was added to the above and the solution was stirred at room temperature for 15 hours. The solvent was removed under vacuum and the reacted MPC was collected on a frit where unreacted materials were removed by 515 washing with 500 mL of acetonitrile followed by sonication/decanting with 50 mL acetonitrile (3X). The following data were obtained: NMR (in C6D6): δ (ppm) = 0.88 (br, 12.8 H), 1.35 (br, 48 H), 3.05 (br, 1.75 H), 3.55 (br, 2.2 H), 4.1 (br, 1.7 H), 4.5 (br, 0.3 H), 7.2 (d, 5 H).
520
Example 14 Deprotection of BOC-Phe-terminated MPC.
To a 30 ml solution of 1.0 g of BOC-Phe-terminated MPC (synthesized in Example 14) in CH2CI2 was added 7.5 ml of trifluoroacetic acid. The reaction
525 was stirred at room temperature for 2 hours after which time the reaction mixture was diluted with 100 ml of distilled H20. The organic phase was separated, and the aqueous phase was further washed with 100 ml of CH2CI2. The combined organic phases were washed with 2 x 100 ml of 10% NaHC03 and then removed in vacuo. The precipitate was then washed with copious quantities of acetonitrile
530 and was air dried. The following data were collected: NMR (in CD2CI2): δ (ppm)
= 0.88 (br, 26 H), 1.35 (br, 192 H), 7.2 (d, 5 H).
Example 15 Coupling of BOC-alanine
535 BOC-alanine was coupled to the C-terminus of phenylalanine as described in Examples 2-8 (five molar excess of reagents). The following data were obtained; NMR (in C6D6): δ (ppm) = 0.85 (br, 13.6 H), 1.35 (br, 115 H), 3.05 (br, 2.6 H), 4.1 (br, 2.5 H), 4.7 (br, 0.6 H), 7.2 (d, 5 H). 540 Example 16
Deprotection of BOC-Ala-Phe-terminated MPC
BOC-alanine was deprotected as described in Example 15. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.85 (br, 16.8 H), 1.35 (br, 156 H), 3.05 (br, 3.4 H), 4.1 (br, 1.9 H), 4.7 (br, 0.7 H), 7.2 (d, 5 H) 7.65 (br, 0.12 H). 545
Example 17 Coupling of BOC-isoleucine BOC-isoleucine was coupled to the C-terminus of alanine as described in Examples 2-8 above (five molar excess of reagents). The following data were 550 obtained: NMR (in C6D6): δ (ppm) = 0.85 (br, 18 H), 1.35 (br, 147 H), 3.05 (br,
2.6 H), 4.1 (br, 2.4 H), 4.7 (br, 0.02 H), 7.2 (d, 5 H). IR: 3063, 3029, 2848 (d+), 2917 (d"), 1738, 1718, 1687, 1644, 1513, 1497, 1164 cm"1.
Example 18 555 Deprotection of BOC-lle-Ala-Phe-terminated MPC
BOC-isoleucine was deprotected as described in Example 15. The following data were obtained: NMR (in CD2CI2): δ (ppm) = 0.85 (br, 16.8 H), 1.35
(br, 156 H), 3.05 (br, 3.4 H), 4.1 (br, 1.9 H), 4.7 (br, 0.7 H), 7.2 (d, 5 H) 7.65 (br,
0.12 H).
560
Example 19
Analysis of ω-Carboxylic Acid-Alkanethiolate Functionalized MPCs using ^ Decomposition
565 Approximately 50 mg of the ω-carboxylic acid-alkanethiolate functionalized MPC was dissolved in dichloromethane and stirred with approximately 3 mg of iodine for one hour. Following disulfide formation, which was monitored by a change in solution color from dark brown to clear violet, the insoluble brown residue (actual identity of insoluble materials not identified) was
570 removed and the sample rotovapped to dryness. The NMR of the l2- decomposed C12:C11COOH (4:1) (in CDCI3) was: δ (ppm) = 0.85 (t, 5.5 H), 1.25 (m, 35.4 H), 1.66 (m, 5.3 H), 2.35 (t,1 H), 2.65 (t,4 H).
Example 20 575 Electrochemical Measurement: Cyclic Voltammetry
Cyclic voltammetry (seen in Figure 2) was performed with a BAS 100B electrochemical analyzer sold by Bioanalytical Systems, Inc., located in West Lafayette, Indiana. A platinum 3 mm diameter working electrode was polished with 0.5 μm diamond (Buehler) paste followed by rinsing with water, ethanol, and
580 acetone prior to each experiment. A Pt coil counter electrode and saturated calomel reference electrode resided in the same ceil compartment as the working electrode. Solutions (2:1 toluene/acetonitrile as disclosed in Ingram et al., J.Am.Chem.Soc 1996, 51, 1093) of the phenothiazine-MPC (0.8 mM in phenothiazine) and of phenothiazine monomer (1 mM) were degassed and then
585 bathed throughout with solvent-saturated N2.
Example 21 Electrochemical Measurement: Thin-layer coulometry
Thin-layer coulometry (as seen in Figure 2b) was performed using a BAS 590 100B electrochemical analyzer. A 4.3 mm diameter Pt working electrode was polished with 0.5 μm of diamond (Buehler) paste followed by rinsing with water, ethanol, and acetone and toluene prior to each experiment. A Pt wire counter electrode and Ag wire quasi-reference electrode (AgQRE) resided in a locally designed thin-layer cell as defined in Reilley, C.N., Pure Appl. Chem. 18 (1968) 595 137. A Mitutoyo digital micrometer (1-2", 0.00005" resolution) sold by Mitutoyo
Corporation of Japan was fitted to the cell and used to define the thin-layer cell thickness, L. Charge-time measurements were performed for cell thicknesses of 2-30 μm, and Q values of zero-time intercepts extrapolated from the longer time plateaus (20-32 s) of each charge-time plot. The product of the number of 600 phenothiazines per cluster, 0, and of electrons per phenothiazine, n, is obtained from the slope of a Q versus L plot as shown in Figure 3b (Q/L = nFAC = 11.47 X 10"3 C/cm, C = 1.07x10"7 mole/cm3).
In the drawings, specification, and examples there have been disclosed typical preferred embodiments of the invention and, although specific terms are employed, they are used in a generic and descriptive sense only and not for the purposes of limitation, the scope of the invention being set forth in the following claims.

Claims

THAT WHICH IS CLAIMED: 610
1. A functionalized nanometer-sized particle comprising: a core comprising at least one metal or metal alloy; and a monolayer chemically bonded to said core, said monolayer containing at least one reactive substituent and wherein at least one reactive substituent is 615 coupled to a functional material such that the monolayer is chemically modified.
2. The particle according to Claim 1 , further including amide or ester linkages which couple at least one reactive substituent and the functional material together.
620
3. The particle according to Claim 1 , wherein said at least one metal or metal alloy is selected from the group consisting of a semiconducting material, a metal oxide material, a Group VIIIA element, a Group IB element, a Group IIB element, alloys thereof, and mixtures thereof.
625
4. The particle according to Claim 1 , wherein said at least one metal or metal alloy is preferably selected from the group consisting of a Group VIIIA element, a Group IB element, a Group IIB element, alloys thereof, and mixtures thereof.
630 5. The particle according to Claim 1 , wherein said core has a diameter ranging from about 1 nm to about 999 nm.
6. The particle according to Claim 1, wherein said core has a diameter ranging from about 1 nm to about 100 nm.
635
7. The particle according to Claim 1 , wherein said monolayer is formed during the formation of said core.
8. The particle according to Claim 1 , wherein said monolayer comprises a 640 material selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof.
9. The particle according to Claim 1 , wherein said monolayer comprises 645 substituents selected from the group consisting of straight-chained molecules, branched molecules, hyperbranched molecules, compounds containing functional groups, and mixtures thereof.
10. The particle according to Claim 1 , wherein said chemically modified
650 monolayer includes materials selected from the group consisting of nonreactive materials, partially reactive materials, and mixtures thereof.
11. The particle according to Claim 1 , wherein said chemically modified monolayer is chemically bonded to said core by a bond selected from the group
655 consisting of a core-element-sulfur bond, a core-element-oxygen bond, a core- element-nitrogen-bond, core-element-phosphorus, core-element-boron, and combinations thereof.
12. The particle according to Claim 1, wherein said monolayer comprises at 660 least one alkanethiol compound or derivative thereof.
13. The particle according to Claim 1 , wherein at least one reactive substituent comprises at least one compound having the general formula:
Rn(EH)x 665 wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, C02, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof; n is an integer ranging from 1 to 5; and x is an integer ranging from 1 to 10.
670
14. The particle according to Claim 1 , wherein the at least one reactive substituent is selected from the group consisting of SH, OH, NH2, NH, C02H, SO3OH, P02(OH)2, BO(OH)2, and mixtures thereof.
675 15. The particle according to Claim 1 , wherein the at least one reactive substituent is selected from the group consisting of OH, NH2, NH, C02H, and mixtures thereof.
16. The particle according to Claim 1 , wherein the at least one functional 680 material coupled to said monolayer comprises functionality selected from the group consisting of SH, OH, NH2, NH, C02H, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof.
17. The particle according to Claim 1 , wherein the at least one functional 685 material coupled to said monolayer comprises functionality selected from the group consisting of OH, NH2, NH, C02H, and mixtures thereof.
18. The particle according to Claim 1, wherein the functional material coupled 690 to said monolayer is a catalyst.
19. The particle according to Claim 1, wherein the functional material coupled to said monolayer is a biomaterial.
695 20. The particle according to Claim 1 , wherein the functional material coupled to said monolayer has a low-lying excited state which is capable of undergoing fluorescence or electron-transfer when excited.
21. The particle according to Claim 1 , wherein the functional material coupled 700 to said monolayer is electrochemically active.
22. A solvent containing a nanometer-sized particle as recited in Claim 1 dissolved therein.
705 23. A method of making a functionalized nanometer-sized particle, said method comprising: providing a nanometer-sized particle comprising a core which comprises at least one metal or metal alloy, and a monolayer adsorbed onto core wherein said monolayer includes at least one reactive substituent; and 710 coupling the nanometer-sized particle with a functional material such the monolayer is chemically modified.
24. The method according to Claim 23, wherein at least one reactive substituent comprises at least one compound having the general formula:
715 Rn(EH)x wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, C02, S03OH, P02(OH)2, BO(OH)2, and mixtures thereof; n is an integer ranging
720 from 1 to 5; and x is an integer ranging from 1 to 10.
25. The method according to Claim 23, wherein the functional material comprises at least one compound having the general formula:
Rn(EH)x 725 wherein R is selected from the group consisting of an organic compound, an inorganic compound, an organometallic compound, a biochemical compound, and mixtures thereof; E is selected from the group consisting of S, O, NH2, NH, C02, S03OH, P02(OH)2, BO(OH)2> and mixtures thereof; n is an integer ranging from 1 to 5; and x is an integer ranging from 1 to 10.
730
26. The particle according to Claim 25, wherein E is selected from the group consisting of O, NH2, NH, C02; n is an integer ranging from 1 to 2; and x is an integer ranging from 1 to 3.
735 27. The method according to Claim 23, wherein the functional material is selected from the group consisting of spin labels, metal ligands, amino acids, chromophores, fluorophores, ionophores, molecules susceptible to functional group conversion, electroactive molecules, sugars, nucleotides, and mixtures thereof.
740
28. The method according to Claim 23, wherein said coupling step is carried out in the presence of a reagent selected from the group consisting of a phosphonium reagent, a facilitating reagent, and mixtures thereof.
745 29. The method according to Claim 28, wherein the facilitating reagent is selected from the group consisting of a base, a catalyst, and mixtures thereof.
30. The method according to Claim 29, wherein the base is a pyridine derivative.
750
31. The method according to Claim 23, wherein said coupling step is carried out in the presence of a component selected from the group consisting of benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate; 1- hydroxybenzotriazole; 4-methylmorpholine; 4-dimethylaminopyridine; and
755 mixtures thereof
32. A method of analyzing a nanometer-sized particle, said method comprising: subjecting a nanometer-sized particle as defined in Claim 1 to an analytical 760 technique such that the composition of the functional materials of the monolayer on said particle is determined.
33. The method according to Claim 32, wherein the analytical technique is selected from the group consisting of NMR spectroscopy, electrochemical
765 techniques, fluorescent emission spectropies, and infrared spectroscopy.
PCT/US1999/007823 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer WO1999061911A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002329859A CA2329859A1 (en) 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer
EP99953384A EP1073902A2 (en) 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer
AU60169/99A AU6016999A (en) 1998-04-20 1999-04-09 Nanometer sized particles containing a reactive monolayer adsorbed thereon and methods of making the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6286398A 1998-04-20 1998-04-20
US09/062,863 1998-04-20

Publications (2)

Publication Number Publication Date
WO1999061911A2 true WO1999061911A2 (en) 1999-12-02
WO1999061911A3 WO1999061911A3 (en) 2000-03-09

Family

ID=22045338

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/007823 WO1999061911A2 (en) 1998-04-20 1999-04-09 Nanometer particles containing a reactive monolayer

Country Status (4)

Country Link
EP (1) EP1073902A2 (en)
AU (1) AU6016999A (en)
CA (1) CA2329859A1 (en)
WO (1) WO1999061911A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032404A2 (en) * 2000-10-16 2002-04-25 Consejo Superior De Investigaciones Cientificas Nanoparticles
US6483125B1 (en) 2001-07-13 2002-11-19 North Carolina State University Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes
US6653653B2 (en) 2001-07-13 2003-11-25 Quantum Logic Devices, Inc. Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes
US6673717B1 (en) 2002-06-26 2004-01-06 Quantum Logic Devices, Inc. Methods for fabricating nanopores for single-electron devices
FR2859117A1 (en) * 2003-08-27 2005-03-04 Commissariat Energie Atomique USE OF NANOPARTICLES WITH A METAL HEART AND DOUBLE ORGANIC COATING AS CATALYSTS AND NANOPARTICLES USEFUL AS CATALYSTS
WO2004108165A3 (en) * 2003-06-09 2005-06-16 Consejo Superior Investigacion Magnetic nanoparticles linked to a lingand
CN1305977C (en) * 2005-03-04 2007-03-21 北京化工大学 Method for modifying the surface of nano inorganic particles by transfer method
JP2008514686A (en) * 2004-10-01 2008-05-08 ミダテック リミテッド Nanoparticles containing antigens and adjuvants, and immunogenic structures
US7563818B2 (en) 2001-11-01 2009-07-21 Cancer Research Technology Limited Photosensitizer functionalised nanoparticles
US8597397B2 (en) 2005-01-14 2013-12-03 Cabot Corporation Production of metal nanoparticles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0426300A1 (en) * 1989-09-29 1991-05-08 Ortho Diagnostic Systems Inc. Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof
EP0428412A2 (en) * 1989-11-16 1991-05-22 Ortho Diagnostic Systems Inc. Method of producing a metal sol reagent containing colloidal metal particles of a preselected size

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0426300A1 (en) * 1989-09-29 1991-05-08 Ortho Diagnostic Systems Inc. Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof
EP0428412A2 (en) * 1989-11-16 1991-05-22 Ortho Diagnostic Systems Inc. Method of producing a metal sol reagent containing colloidal metal particles of a preselected size

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7364919B2 (en) 2000-10-16 2008-04-29 Midatech Limited Nanoparticles
WO2002032404A3 (en) * 2000-10-16 2002-08-22 Consejo Superior Investigacion Nanoparticles
JP2009242418A (en) * 2000-10-16 2009-10-22 Consejo Superior De Investigaciones Cientificas Nanoparticles
WO2002032404A2 (en) * 2000-10-16 2002-04-25 Consejo Superior De Investigaciones Cientificas Nanoparticles
US8790934B2 (en) 2000-10-16 2014-07-29 Consejo Superior De Investigaciones Cientificas Nanoparticles
EP1671625A1 (en) * 2000-10-16 2006-06-21 Consejo Superior De Investigaciones Cientificas Nanoparticles
US8080431B2 (en) 2000-10-16 2011-12-20 Midatech Limited Nanoparticles
US6483125B1 (en) 2001-07-13 2002-11-19 North Carolina State University Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes
US6653653B2 (en) 2001-07-13 2003-11-25 Quantum Logic Devices, Inc. Single-electron transistors and fabrication methods in which a projecting feature defines spacing between electrodes
US6784082B2 (en) 2001-07-13 2004-08-31 North Carolina State University Methods of fabricating single electron transistors in which the thickness of an insulating layer defines spacing between electrodes
US7563818B2 (en) 2001-11-01 2009-07-21 Cancer Research Technology Limited Photosensitizer functionalised nanoparticles
US6673717B1 (en) 2002-06-26 2004-01-06 Quantum Logic Devices, Inc. Methods for fabricating nanopores for single-electron devices
EP2486944A1 (en) * 2003-06-09 2012-08-15 Consejo Superior De Investigaciones Científicas Magnetic nanoparticles
US8557607B2 (en) 2003-06-09 2013-10-15 Consejo Superior De Investigacione Cientificas Magnetic nanoparticles
WO2004108165A3 (en) * 2003-06-09 2005-06-16 Consejo Superior Investigacion Magnetic nanoparticles linked to a lingand
EP2277548A3 (en) * 2003-06-09 2011-04-27 Consejo Superior De Investigaciones Cientificas Magnetic nanoparticles linked to a ligand
FR2859117A1 (en) * 2003-08-27 2005-03-04 Commissariat Energie Atomique USE OF NANOPARTICLES WITH A METAL HEART AND DOUBLE ORGANIC COATING AS CATALYSTS AND NANOPARTICLES USEFUL AS CATALYSTS
US7595108B2 (en) 2003-08-27 2009-09-29 Commissariat A L'energie Atomique Nanoparticles comprising a metal core and an organic double coating useful as catalysts and device containing the nanoparticles
JP4772677B2 (en) * 2003-08-27 2011-09-14 コミッサリア ア レネルジー アトミーク エ オ ゼネルジ ザルタナテイヴ Use of nanoparticles having metal cores and organic double coatings as catalysts, and nanoparticles useful as catalysts
JP2007503302A (en) * 2003-08-27 2007-02-22 コミツサリア タ レネルジー アトミーク Use of nanoparticles having metal cores and organic double coatings as catalysts, and nanoparticles useful as catalysts
WO2005021154A1 (en) * 2003-08-27 2005-03-10 Commissariat A L'energie Atomique Use of nanoparticles with a metallic core and a double organic coating as catalysts, and nanoparticles used for same
JP2008514686A (en) * 2004-10-01 2008-05-08 ミダテック リミテッド Nanoparticles containing antigens and adjuvants, and immunogenic structures
US8597397B2 (en) 2005-01-14 2013-12-03 Cabot Corporation Production of metal nanoparticles
CN1305977C (en) * 2005-03-04 2007-03-21 北京化工大学 Method for modifying the surface of nano inorganic particles by transfer method

Also Published As

Publication number Publication date
CA2329859A1 (en) 1999-12-02
WO1999061911A3 (en) 2000-03-09
EP1073902A2 (en) 2001-02-07
AU6016999A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
Templeton et al. Gateway reactions to diverse, polyfunctional monolayer-protected gold clusters
Jia et al. Bioactivity-protected electrochemiluminescence biosensor using gold nanoclusters as the low-potential luminophor and Cu2S snowflake as co-reaction accelerator for procalcitonin analysis
JP3791930B2 (en) Graphite nanotubes in luminescence assays
Fox et al. Fluorescence and redox activity of probes anchored through an aminotrithiol to polycrystalline gold
EP1042508B1 (en) Methods for improved luminescence assays using microparticles
EP2286234B1 (en) Novel au-ag core-shell composite useful for biosensor
NZ514682A (en) Monolayer and electrode for detecting a label-bearing target and method of use thereof
Qi et al. Functionalization of single-walled carbon nanotubes with protein by click chemistry as sensing platform for sensitized electrochemical immunoassay
CN110438200A (en) A kind of biosensor for heavy metal lead ion detection based on dual signal amplification
JP2008502715A (en) New DNA stitching intercalator
EP1073902A2 (en) Nanometer particles containing a reactive monolayer
Taira et al. Electrode modification by long-chain, dialkyl disulfide reagent having terminal dinitrophenyl group and its application to impedimetric immunosensors
US20040048272A1 (en) Dendritically amplified detection method
US9157161B1 (en) Multifunctional thin film surface
JP2004022424A (en) Material for photoelectric transducing element containing host-guest complex
Ahmadpor et al. A comparative study of different techniques for quantum dot nano-particles immobilization on glass surface for fabrication of solid phase fluorescence opto-sensors
US7321831B2 (en) Nucleic acid fragment-fixed electrode and its use
Lu et al. The characterization of 5-{[4-(4-mercapto) phenylmethoxy] phenyl}-10, 15, 20-tris (phenyl) porphyrin cobalt (II) self-assembled monolayers (SAMs) and its electrocatalytic oxidation for ascorbic acid
Wang et al. Polyviologen synthesis by self-assembly assisted grafting
WO2020232353A1 (en) Sensors and methods using electrochemiluminescence of metal nanoclusters
US7005268B2 (en) Detection of biopolymers utilizing photo-initiated charge separation
Adams Luminescent surface-active transition metal complexes as probes for sensing and supramolecular recognition architectures
Tabassum et al. Future and commercialization aspects of photoelectrochemical bioanalysis
US20080166712A1 (en) Gene detection method
Carducci et al. 3 Electrochemistry of Monolayer-Protected Clusters

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase in:

Ref country code: KR

ENP Entry into the national phase in:

Ref document number: 2329859

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1999953384

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999953384

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999953384

Country of ref document: EP